NASDAQ:ABSI Absci (ABSI) Stock Price, News & Analysis → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free ABSI Stock Alerts $5.68 +0.14 (+2.53%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$5.51▼$5.7650-Day Range$3.41▼$5.7452-Week Range$1.11▼$6.40Volume1.22 million shsAverage Volume1.57 million shsMarket Capitalization$640.65 millionP/E RatioN/ADividend YieldN/APrice Target$9.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Absci alerts: Email Address Absci MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside62.9% Upside$9.25 Price TargetShort InterestBearish13.25% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.01Based on 16 Articles This WeekInsider TradingAcquiring Shares$999,999 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.77) to ($0.65) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.93 out of 5 starsMedical Sector646th out of 938 stocksCommercial Physical Research Industry9th out of 10 stocks 3.5 Analyst's Opinion Consensus RatingAbsci has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.25, Absci has a forecasted upside of 62.9% from its current price of $5.68.Amount of Analyst CoverageAbsci has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted13.25% of the float of Absci has been sold short.Short Interest Ratio / Days to CoverAbsci has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Absci has recently increased by 0.56%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAbsci does not currently pay a dividend.Dividend GrowthAbsci does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ABSI. Previous Next 1.7 News and Social Media Coverage News SentimentAbsci has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Absci this week, compared to 1 article on an average week.Search InterestOnly 19 people have searched for ABSI on MarketBeat in the last 30 days. This is a decrease of -42% compared to the previous 30 days.MarketBeat Follows27 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 145% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Absci insiders have bought more of their company's stock than they have sold. Specifically, they have bought $999,999.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.58% of the stock of Absci is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.05% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Absci are expected to grow in the coming year, from ($0.77) to ($0.65) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Absci is -4.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Absci is -4.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAbsci has a P/B Ratio of 2.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Absci Stock (NASDAQ:ABSI)Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.Read More ABSI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABSI Stock News HeadlinesMarch 28, 2024 | finance.yahoo.comAbsci to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 27, 2024 | americanbankingnews.comAbsci's (ABSI) Buy Rating Reaffirmed at Truist FinancialMarch 29, 2024 | Crypto 101 Media (Ad)Major Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.March 26, 2024 | americanbankingnews.comAbsci's (ABSI) "Outperform" Rating Reaffirmed at ScotiabankMarch 23, 2024 | finance.yahoo.comAbsci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net LossMarch 23, 2024 | americanbankingnews.comAbsci's (ABSI) "Buy" Rating Reiterated at HC WainwrightMarch 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for AbSci: Promising Pipeline and Strategic Partnerships Signal GrowthMarch 21, 2024 | benzinga.comAbsci: Q4 Earnings InsightsMarch 29, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… March 21, 2024 | investorplace.comABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q4 2023March 21, 2024 | globenewswire.comAbsci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsMarch 13, 2024 | finance.yahoo.comABSI Apr 2024 6.000 callMarch 7, 2024 | investing.comAbsci shares get buy rating, $9 target on AI biotech potentialMarch 1, 2024 | finance.yahoo.comAbsci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesMarch 1, 2024 | globenewswire.comAbsci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional SharesFebruary 28, 2024 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on AbSci (ABSI)February 28, 2024 | msn.comWhy Absci (ABSI) Shares Are FallingFebruary 28, 2024 | msn.comAbsci prices $75M equity offering at $4.50 per shareFebruary 27, 2024 | globenewswire.comAbsci Announces Pricing of Public Offering of Common StockFebruary 27, 2024 | globenewswire.comAbsci Announces Proposed Public Offering of Common StockFebruary 24, 2024 | ca.finance.yahoo.comCNC Mar 2024 86.000 callFebruary 21, 2024 | finance.yahoo.comIs Centene (CNC) Stock Outpacing Its Medical Peers This Year?February 21, 2024 | finance.yahoo.comAbsci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AIFebruary 21, 2024 | globenewswire.comAbsci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AIFebruary 16, 2024 | finance.yahoo.comABSI Mar 2024 7.500 callFebruary 16, 2024 | finance.yahoo.comABSI Feb 2024 7.500 putFebruary 5, 2024 | finance.yahoo.comIs Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year?See More Headlines Receive ABSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today3/28/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:ABSI CUSIPN/A CIK1672688 Webwww.absci.com Phone360-949-1041FaxN/AEmployees193Year FoundedN/APrice Target and Rating Average Stock Price Target$9.25 High Stock Price Target$13.00 Low Stock Price Target$7.00 Potential Upside/Downside+62.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-110,570,000.00 Net Margins-1,933.65% Pretax Margin-1,931.90% Return on Equity-44.52% Return on Assets-37.35% Debt Debt-to-Equity Ratio0.03 Current Ratio4.08 Quick Ratio4.08 Sales & Book Value Annual Sales$5.72 million Price / Sales112.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.90 per share Price / Book2.99Miscellaneous Outstanding Shares112,790,000Free Float99,724,000Market Cap$640.65 million OptionableOptionable Beta2.35 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Sean McClain (Age 34)Founder, CEO, President & Director Comp: $936.2kDr. Zachariah Jonasson Ph.D. (Age 50)Chief Business Officer & CFO Comp: $98.3kDr. Andreas Busch Ph.D. (Age 61)Chief Innovation Officer & Member of Scientific Advisory Board Comp: $1.56MMr. Todd Bedrick CPASenior VP & Chief Accounting OfficerMr. Alexander Khan CPAVP of Finance & Head of Investor RelationsMr. Jack GoldChief Marketing OfficerMs. Karin WierinckChief People OfficerMelissa Patterson Ph.D.Chief of StaffJens Plassmeier Ph.D.Senior VP of Biologics Discovery TechnologyMr. Wen ShaChief of StaffMore ExecutivesKey CompetitorsOmniAbNASDAQ:OABIMaxCyteNASDAQ:MXCTHarpoon TherapeuticsNASDAQ:HARPTScan TherapeuticsNASDAQ:TCRXTenaya TherapeuticsNASDAQ:TNYAView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 110,035 shares on 3/11/2024Ownership: 2.772%Redmile Group, LlcBought 222,222 shares on 3/1/2024Total: $999,999.00 ($4.50/share)Vanguard Group Inc.Bought 109,289 shares on 2/15/2024Ownership: 2.771%Bridgeway Capital Management LLCBought 18,500 shares on 2/15/2024Ownership: 0.291%Citadel Advisors LLCSold 7,000 shares on 2/15/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions ABSI Stock Analysis - Frequently Asked Questions Should I buy or sell Absci stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Absci in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ABSI shares. View ABSI analyst ratings or view top-rated stocks. What is Absci's stock price target for 2024? 4 brokerages have issued 12-month target prices for Absci's stock. Their ABSI share price targets range from $7.00 to $13.00. On average, they expect the company's stock price to reach $9.25 in the next twelve months. This suggests a possible upside of 62.9% from the stock's current price. View analysts price targets for ABSI or view top-rated stocks among Wall Street analysts. How have ABSI shares performed in 2024? Absci's stock was trading at $4.20 on January 1st, 2024. Since then, ABSI shares have increased by 35.2% and is now trading at $5.68. View the best growth stocks for 2024 here. When is Absci's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our ABSI earnings forecast. How were Absci's earnings last quarter? Absci Co. (NASDAQ:ABSI) posted its earnings results on Thursday, March, 21st. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by $0.02. The firm had revenue of $0.34 million for the quarter, compared to analyst estimates of $1.75 million. Absci had a negative net margin of 1,933.65% and a negative trailing twelve-month return on equity of 44.52%. When did Absci IPO? Absci (ABSI) raised $200 million in an initial public offering (IPO) on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share. Who are Absci's major shareholders? Absci's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.77%), Vanguard Group Inc. (2.77%), Platinum Investment Management Ltd. (0.90%), Hsbc Holdings PLC (0.44%), Charles Schwab Investment Management Inc. (0.38%) and Bridgeway Capital Management LLC (0.29%). Insiders that own company stock include Karen K Mcginnis, Redmile Group, Llc, Sarah Korman, Sean Mcclain and Todd Bedrick. View institutional ownership trends. How do I buy shares of Absci? Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ABSI) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.